We are live on ! Find out more
OL

Odyssean LLC Portfolio holdings

AUM $866M Turnover 38.09%
1-Year Est. Return 42.65%
This Fund
S&P 500
This Quarter Est. Return
+3.71%
1 Year Est. Return
+42.65%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$866M
AUM Growth
+$251M
Cap. Flow
+$260M
Cap. Flow %
30.08%
Top 10 Hldgs %
5.29%
Holding
575
New
90
Increased
217
Reduced
38
Closed
129
Avg Time Held
0.4 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0.1 years

Sector Composition

Rank Sector Weight
1 Technology 27.33%
2 Healthcare 16.37%
3 Financials 15.49%
4 Industrials 8.24%
5 Real Estate 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VKTX icon
151
Viking Therapeutics
VKTX
$3.19B
$2.5M 0.29%
76,559
+1,572
+2% +$54.5K
2025 Q4
3 quarters
INSP icon
152
Inspire Medical Systems
INSP
$1.6B
$2.49M 0.29%
35,876
+9,594
+37% +$573K
2026 Q2
1 quarter
UNP icon
153
Union Pacific
UNP
$172B
$2.48M 0.29%
9,108
+6,018
+195% +$1.75M
2026 Q1
2 quarters
ADI icon
154
Analog Devices
ADI
$171B
$2.46M 0.28%
6,200
+4,023
+185% +$1.52M
2026 Q1
2 quarters
TTD icon
155
Trade Desk
TTD
$6.48B
$2.44M 0.28%
200,467
+139,699
+230% +$2.19M
2025 Q4
3 quarters
META icon
156
Meta Platforms (Facebook)
META
$1.44T
$2.41M 0.28%
3,328
– –
2025 Q4
3 quarters
WRBY icon
157
Warby Parker
WRBY
$2.93B
$2.4M 0.28%
86,399
+47,954
+125% +$1.25M
2025 Q4
3 quarters
HNGE icon
158
Hinge Health
HNGE
$8.57B
$2.36M 0.27%
+24,260
New +$2.13M
2026 Q3
0 quarters
BHVN icon
159
Biohaven
BHVN
$1.92B
$2.3M 0.27%
+171,957
New +$2.49M
2026 Q3
0 quarters
BRZE icon
160
Braze
BRZE
$5.26B
$2.25M 0.26%
89,662
+49,890
+125% +$1.34M
2025 Q4
3 quarters
CELC icon
161
Celcuity
CELC
$2.65B
$2.24M 0.26%
+28,204
New +$2.57M
2026 Q3
0 quarters
VNO icon
162
Vornado Realty Trust
VNO
$6.09B
$2.23M 0.26%
65,690
-11,990
-15% -$454K
2026 Q2
1 quarter
EEFT icon
163
Euronet Worldwide
EEFT
$2.39B
$2.22M 0.26%
35,380
-9,217
-21% -$671K
2025 Q4
3 quarters
GH icon
164
Guardant Health
GH
$19.6B
$2.21M 0.26%
12,379
+2,108
+21% +$344K
2026 Q2
1 quarter
TXN icon
165
Texas Instruments
TXN
$245B
$2.21M 0.25%
7,879
+4,729
+150% +$1.31M
2026 Q2
1 quarter
SMA icon
166
SmartStop Self Storage REIT
SMA
$2.23B
$2.2M 0.25%
+68,352
New +$2.28M
2026 Q3
0 quarters
SXC icon
167
SunCoke Energy
SXC
$810M
$2.1M 0.24%
222,291
+129,952
+141% +$1.2M
2026 Q2
1 quarter
BRK.B icon
168
Berkshire Hathaway Class B
BRK.B
$1.21T
$2.07M 0.24%
4,156
-1,920
-32% -$969K
2026 Q1
2 quarters
CORT icon
169
Corcept Therapeutics
CORT
$6.86B
$2.06M 0.24%
17,878
+3,607
+25% +$388K
2025 Q4
3 quarters
VIK icon
170
Viking Holdings
VIK
$41.8B
$1.98M 0.23%
25,270
-6,956
-22% -$654K
2025 Q4
3 quarters
IOT icon
171
Samsara
IOT
$22.2B
$1.96M 0.23%
51,403
+10,440
+25% +$400K
2026 Q1
2 quarters
ADPT icon
172
Adaptive Biotechnologies
ADPT
$4.49B
$1.96M 0.23%
67,709
– –
2025 Q4
3 quarters
VOYG icon
173
Voyager Technologies
VOYG
$1.19B
$1.95M 0.23%
+64,414
New +$2.14M
2026 Q3
0 quarters
OKLO icon
174
Oklo
OKLO
$3.94B
$1.94M 0.22%
52,347
+41,739
+393% +$1.76M
2026 Q2
1 quarter
RDDT icon
175
Reddit
RDDT
$16.7B
$1.89M 0.22%
+13,296
New +$2.2M
2026 Q3
0 quarters

Similar funds

Odyssean LLC's Q3 2026 Portfolio in Review

As of Q3 2026, Odyssean LLC held 575 positions worth $866M, up 41% from $615M the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.

Odyssean LLC deployed $260M of net new capital in Q3 2026, opening 90 new positions and adding to 217 existing holdings. Its largest new stake was BILL Holdings: 101,841 shares worth $4.33M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Mirum Pharmaceuticals, an estimated $1.83M trimmed.

  • Odyssean LLC's largest Q3 2026 buy was BILL Holdings: 101,841 shares worth $4.33M.
  • Odyssean LLC added most to Broadstone Net Lease in Q3 2026, an estimated $4.24M increase.
  • Odyssean LLC's biggest Q3 2026 reduction was Mirum Pharmaceuticals, cutting an estimated $1.83M.
  • Odyssean LLC fully exited Ultragenyx Pharmaceutical in Q3 2026, selling an estimated $4.08M.
  • Odyssean LLC's ten largest holdings make up 5.3% of its $866M portfolio in Q3 2026.
  • Odyssean LLC opened 90 new positions and closed 129 in Q3 2026.
  • Odyssean LLC's portfolio value rose 41% quarter-over-quarter to $866M.

Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.